Healthcare

Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday, delivering revenue and...

Coherus BioSciences has secured a significant partnership for its clinical development efforts, aligning with Janssen Research & Development, a Johnson...

Akso Health Group has solidified its strategic shift into the healthcare industry with the launch of a major global program...

Since its acquisition by the private equity firm Sycamore Partners was finalized in the summer of 2025, Walgreens has embarked...

The recent foray by telehealth company Hims & Hers into the lucrative weight-loss medication sector has hit an early regulatory...

Despite posting impressive fourth-quarter 2025 results, Intuitive Surgical's forward-looking guidance has unsettled investors. The stock has retreated significantly from recent...

NextGen Healthcare continues to demonstrate robust market strength, underscored by a key new client partnership and a series of prestigious...

Investors are marking their calendars for a pivotal date in late February 2026. National Healthcare is poised to release its...

Biopharmaceutical firm aTyr Pharma (ATYR) has scheduled a critical regulatory discussion with the U.S. Food and Drug Administration (FDA) for...

All eyes are on Align Technology as the company prepares to release its fourth-quarter financial results after today's market close....